Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 96

    3.

    Lasting improvement of hyperglycaemia and bodyweight: low-carbohydrate diet in type 2 diabetes--a brief report.

    Nielsen JV, Jönsson E, Nilsson AK.

    Ups J Med Sci. 2005;110(1):69-73.PMID: 15801687 [PubMed - indexed for MEDLINE]Related articles

    4.

    Lasting improvement of hyperglycaemia and bodyweight: low-carbohydrate diet in type 2 diabetes. A brief report.

    Nielsen JV, Jönsson E, Nilsson AK.

    Ups J Med Sci. 2005;110(2):179-83.PMID: 16075898 [PubMed - indexed for MEDLINE]Related articles

    5.

    The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein.

    Wolever TM, Gibbs AL, Mehling C, Chiasson JL, Connelly PW, Josse RG, Leiter LA, Maheux P, Rabasa-Lhoret R, Rodger NW, Ryan EA.

    Am J Clin Nutr. 2008 Jan;87(1):114-25.PMID: 18175744 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effects of a low-carbohydrate diet on glycemic control in outpatients with severe type 2 diabetes.

    Haimoto H, Sasakabe T, Wakai K, Umegaki H.

    Nutr Metab (Lond). 2009 May 6;6:21.PMID: 19419563 [PubMed - in process]Related articlesFree article

    7.

    Dietary advice for treatment of type 2 diabetes mellitus in adults.

    Nield L, Moore HJ, Hooper L, Cruickshank JK, Vyas A, Whittaker V, Summerbell CD.

    Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004097. Review.PMID: 17636747 [PubMed - indexed for MEDLINE]Related articles

    8.

    A low-carbohydrate diet may prevent end-stage renal failure in type 2 diabetes. A case report.

    Nielsen JV, Westerlund P, Bygren P.

    Nutr Metab (Lond). 2006 Jun 14;3:23.PMID: 16774676 [PubMed]Related articlesFree article

    9.

    Sustained beneficial metabolic effects 18 months after a 30-day very low calorie diet in severely obese, insulin-treated patients with type 2 diabetes.

    Jazet IM, de Craen AJ, van Schie EM, Meinders AE.

    Diabetes Res Clin Pract. 2007 Jul;77(1):70-6. Epub 2006 Nov 28.PMID: 17134786 [PubMed - indexed for MEDLINE]Related articles

    10.

    The effects of a low-carbohydrate versus low-fat diet on adipocytokines in severely obese adults: three-year follow-up of a randomized trial.

    Cardillo S, Seshadri P, Iqbal N.

    Eur Rev Med Pharmacol Sci. 2006 May-Jun;10(3):99-106.PMID: 16875041 [PubMed - indexed for MEDLINE]Related articles

    11.

    Low glycaemic index diet and disposition index in type 2 diabetes (the Canadian trial of carbohydrates in diabetes): a randomised controlled trial.

    Wolever TM, Mehling C, Chiasson JL, Josse RG, Leiter LA, Maheux P, Rabasa-Lhoret R, Rodger NW, Ryan EA.

    Diabetologia. 2008 Sep;51(9):1607-15. Epub 2008 Jul 22.PMID: 18648764 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effects of a low-glycemic load vs low-fat diet in obese young adults: a randomized trial.

    Ebbeling CB, Leidig MM, Feldman HA, Lovesky MM, Ludwig DS.

    JAMA. 2007 May 16;297(19):2092-102. Erratum in: JAMA. 2007 Aug 8;298(6):627. PMID: 17507345 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Improvement of glycemic control after a 3-5 day insulin infusion in type 2-diabetic patients with insulin resistance can be maintained with glitazone therapy.

    Biesenbach G, Grafinger P, Raml A.

    Wien Klin Wochenschr. 2006 Sep;118(17-18):543-8.PMID: 17009067 [PubMed - indexed for MEDLINE]Related articles

    14.

    Changes in depressive symptoms and glycemic control in diabetes mellitus.

    Georgiades A, Zucker N, Friedman KE, Mosunic CJ, Applegate K, Lane JD, Feinglos MN, Surwit RS.

    Psychosom Med. 2007 Apr;69(3):235-41. Epub 2007 Apr 9.PMID: 17420441 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    A modified Mediterranean diet is associated with the greatest reduction in alanine aminotransferase levels in obese type 2 diabetes patients: results of a quasi-randomised controlled trial.

    Fraser A, Abel R, Lawlor DA, Fraser D, Elhayany A.

    Diabetologia. 2008 Sep;51(9):1616-22. Epub 2008 Jul 3.PMID: 18597068 [PubMed - indexed for MEDLINE]Related articles

    16.

    Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.

    Derosa G, D'Angelo A, Ragonesi PD, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo SA, Montagna L, Gravina A, Ferrari I, Paniga S, Cicero AF.

    J Clin Pharm Ther. 2006 Aug;31(4):375-83.PMID: 16882108 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effects of a reduced-glycemic-load diet on body weight, body composition, and cardiovascular disease risk markers in overweight and obese adults.

    Maki KC, Rains TM, Kaden VN, Raneri KR, Davidson MH.

    Am J Clin Nutr. 2007 Mar;85(3):724-34.PMID: 17344493 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Beneficial effects of ketogenic diet in obese diabetic subjects.

    Dashti HM, Mathew TC, Khadada M, Al-Mousawi M, Talib H, Asfar SK, Behbahani AI, Al-Zaid NS.

    Mol Cell Biochem. 2007 Aug;302(1-2):249-56. Epub 2007 Apr 20.PMID: 17447017 [PubMed - indexed for MEDLINE]Related articles

    19.

    An 18-mo randomized trial of a low-glycemic-index diet and weight change in Brazilian women.

    Sichieri R, Moura AS, Genelhu V, Hu F, Willett WC.

    Am J Clin Nutr. 2007 Sep;86(3):707-13.PMID: 17823436 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study.

    Scheen AJ, Finer N, Hollander P, Jensen MD, Van Gaal LF; RIO-Diabetes Study Group.

    Lancet. 2006 Nov 11;368(9548):1660-72. Erratum in: Lancet. 2006 Nov 11;368(9548):1650. PMID: 17098084 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data